Mehta, P., Thummar, V. and Bhavsar, H. (2026) “Clinical outcomes of neoadjuvant dual HER2 blockade with pertuzumab/Sigrima and trastuzumab/Vivitra biosimilars: real-world evidence in HER2-positive breast cancer in India”, International Journal of Research in Medical Sciences, 14(4), pp. 1584–1588. doi: 10.18203/2320-6012.ijrms20260973.